Frontierby eninvs

Language: EN · RU

← Region

United Medical Group USD

Update

Re-runs extraction for each period with period-end year from max(2023, current year − 2) through the current year, oldest first (up to three reporting years). This can take a long time.

Sector: Healthcare

RU_GEMC

Price chart

735 RUBDay 0.18%

Key metrics

Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.

Market

Price
735 RUB · 0.18%
Market cap
928 mln USD

Growth

Δ revenue y/y
5.8%
Δ EBITDA y/y
-11.7%

Multiples

P/E (LTM)
5.7x
3y avg: 8.5x
P/B (FY)
1.8x
P/E (ann.)
37.7x
EV/EBITDA (LTM)
87.1x
3y avg: 64.7x
EV/EBITDA (ann.)
81.8x

Cash return

Dividend yield
—
FCF yield (LTM)
—

Liquidity

Daily turnover (MOEX)
7.2 mln RUB

Shares: connector/market_inputs

Amounts: USD (converted) · As reported
Converted modes use NBK / ECB-linked rates: balance sheet date for BS items, period average for P&L and cash flow (see filing row evidence). As reported keeps each row in its filing currency.

🔍 Sanity check — subtotal consistency (Level-1 + Level-2) OK: 3 / Warn: 1 / Err: 5 / Autofix applied: 0
Port of PHP subtotal-total + sign-flip detection logic
PeriodIssues
2023-06-30 H1✓OK
2023-12-31 FY✓OK
2023-12-31 H2✓OK
2024-06-30 H1✗Errors 1Warn 1
2024-12-31 FY✗Errors 1Warn 1
2024-12-31 H2✗Errors 1Warn 2
2025-06-30 H1⚠Warn 2
2025-12-31 FY✗Errors 1Warn 1
2025-12-31 H2✗Errors 2Warn 1
✓ All checks pass · ⚠ Has warnings (review) · ✗ Has errors (needs fix) · ✓* Autofix applied (see evidence)

Financial dynamics

Monetary columns are in M USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.

DatePeriodStatusRevenueM USDOperating profitM USDD&AM USDEBITDAM USDNet profitM USDOperating CFM USDCapex + M&AM USDAssetsM USDEquityM USDROE (annualized)Net debtM USDSource
2025-12-31FY 2025 (12M)OK203.5
y/y 6.1%
64.6
y/y -20.3%
17.8
y/y 47.3%
82.4
y/y -11.5%
87.0
y/y -3.7%
86.3-294.6870.9
y/y 61.0%
506.6
y/y 29.9%
17.9%12557.1—
2025-06-30Q2 2025 (3M)OK176.6
y/y 1.9%
60.5
y/y -0.5%
11.9
y/y 2.1%
72.4
y/y -0.1%
74.7
y/y 25.7%
93.3-4.3598.7
y/y 20.9%
467.8
y/y 52.2%
34.9%-11573.0—
2024-12-31FY 2024 (12M)OK191.9
y/y -13.2%
81.1
y/y -2.9%
12.1
y/y -17.8%
93.2
y/y -5.1%
90.3
y/y 6.8%
99.346.1541.0
y/y 12.2%
390.0
y/y 50.3%
43.0%-5180.3—
2024-06-30Q2 2024 (3M)OK173.3
y/y 6.3%
60.8
y/y 12.6%
11.6
y/y -4.9%
72.5
y/y 9.4%
59.5
y/y -6.2%
74.250.6495.4
y/y 1.0%
307.3
y/y 56.5%
42.0%1227.7—
2023-12-31FY 2023 (12M)OK221.1
y/y —
83.5
y/y —
14.7
y/y —
98.2
y/y —
84.6
y/y —
87.3-70.6482.4
y/y —
259.5
y/y —
64.9%5821.4—
2023-06-30Q2 2023 (3M)OK163.0
y/y —
54.0
y/y —
12.2
y/y —
66.3
y/y —
63.4
y/y —
61.5-11.4490.3
y/y —
196.4
y/y —
—10085.2—
Data quality No obvious scale, balance-sheet, or cash-flow sanity issues in the displayed periods.

Revenue & EBITDA

RevenueEBITDA

Quarterly values ($ mln)

0501001502002023 H12023 H22024 H12024 H22025 H12025 H2

Year-over-year change

-20%-10%0%10%2023 H12023 H22024 H12024 H22025 H12025 H2

Cash flow

Net debt / cash ($ mln)

-15 000-10 000-5 00005 00010 00015 0002023 H12023 FY2024 H12024 FY2025 H12025 FY

Dividends

No dividend rows found for this issuer.

Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)